Primary and secondary prevention of sudden cardiac death in the ICD Registry-Latin America;Prevención primaria y secundaria de muerte súbita en el ICD Registry Latin America

Archivos de Cardiologia de Mexico

Volumn 78, Issue 4, 2008, Pages 400-406

  Ramos, José L ^a,b   Muratore, Claudio ^b   Pachón Mateos, José C ^c   Rodríguez, Ángel ^d   González Hermosillo, Antonio ^e   Asenjo, René ^f   Rodríguez, Diego ^g   Galvao, Silas ^b   Duque, Mauricio ^h   Escudero, Jaime ⁱ   Reyes Caorsi, Walter ^j   Cuvillier, Erick ^b   Maloney, Jennifer ^b  

^a HOSPITAL ITALIANO DE BUENOS AIRES   (Argentina)

^b Medtronic Latinoamérica ^*  (Argentina)

^c Hospital del Corazón   (Brazil)

^d VA MEDICAL CENTER   (Puerto Rico)

^e INSTITUTO NACIONAL DE CARDIOLOGÍA IGNACIO CHÁVEZ   (Mexico)

^f UNIVERSIDAD DEL DESARROLLO   (Chile)

^g Fundacion Santa Fe   (Colombia)

^h Clinica Medellin   (Colombia)

ⁱ Hospital Carlos Arévalo   (Venezuela)

^j Sanatorio Casa de Galicia   (Uruguay)

more..

Author keywords

Defibrillator; Registry; Sudden cardiac death

Indexed keywords

AMIODARONE; ANGIOTENSIN RECEPTOR ANTAGONIST; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR;

ADULT; AGED; ARTICLE; CONTROLLED STUDY; DEFIBRILLATOR; DISEASE CLASSIFICATION; DISEASE REGISTRY; FEMALE; FOLLOW UP; HEART DEATH; HEART LEFT VENTRICLE EJECTION FRACTION; HOSPITALIZATION; HUMAN; IMPLANT; MAJOR CLINICAL STUDY; MALE; MORTALITY; PRIMARY PREVENTION; SECONDARY PREVENTION; SOUTH AND CENTRAL AMERICA; SUDDEN DEATH;

ADRENERGIC BETA-ANTAGONISTS; ANGIOTENSIN II TYPE 1 RECEPTOR BLOCKERS; ANGIOTENSIN-CONVERTING ENZYME INHIBITORS; DEATH, SUDDEN, CARDIAC; DEFIBRILLATORS, IMPLANTABLE; FEMALE; HUMANS; LATIN AMERICA; MALE; MIDDLE AGED; REGISTRIES; STROKE VOLUME;

EID: 58149216478     PISSN: 14059940     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (17)

1. The antiarrhythmics versus implantable defibrillator (AVID) investigators. A comparison of antiarrhythmic-drug therapy with implantable defibrillators in patients resuscitated from near-fatal ventricular arrhythmias. N Engl J Med 1997; 337: 1576-1583.
2. CONNOLLY SJ, GENT M, ROBERTS RS, DORIAN P, ROY D, SHELDON RS, MITCHELL LB, ET AL: Canadian implantable defibrillator study (CIDS): A randomized trial of the implantable cardioverter defibrillator against amiodarone. Circulation 2000; 101: 1297-1302.
3. KUCK KH, CAPPATO R, SIEBELS J, RUPPEL R: Randomized comparison of antiarrhythmia drug therapy with implantable defibrillators in patients resuscitated from cardiac arrest: The Cardiac Arrest Study Hamburg (CASH). Circulation 2000; 102: 748-754.
4. MOSS AJ, ZAREBA W, HALL WJ, KLEIN H, WILBER DJ, CANNOM DS, DAUBERT JP, ET AL: Prophylactic implantation of a defibrillator in patients with myocardial infarction and reduced ejection fraction. N Engl J Med 2002; 346: 877-883.
5. BARDY GH, LEE KL, MARK DB, POOLE JE, PACKER DL, BOINEAU R, DOMANSKI M, ET AL: Amiodarone or an implantable cardioverter-defibrillator for congestive heart failure. N Engl J Med 2005; 352: 225-237.
6. BRISTOW MR, SAXON LA, BOEHMER J, KRUEGER S, KASS DA, DE MARCO T, CARSON P, ET AL: Cardiac-resynchronization therapy with or without an implantable defibrillator in advanced chronic heart failure. N Engl J Med 2004; 350: 2140-2150.
7. ZIPES DP, CAMM J, BORGGRFE M, BUXTON AE, CHAITMAN B, FROMER M ET AL: Ventricular Arrhythmias and Prevention of Sudden Cardiac Death. Rev Esp Cardiol 2006; 59(12): 1328.
8. ACC/AHA/ESC 2006 Guidelines for management of Patients With Ventricular Arrhythmias and the Prevention of Sudden Cardiac Death-Executive Summary. JACC 2006; 48: 1064-1108.
9. PROCLEMER A, GHIDINA M, CICUTTINI G, GREGORI D, FIORETTI PM: Impact of the Main Implantable Cardioverter-Defibrillator Trials for Primary and Secondary Prevention in Italy: A Survey of the National Activity During the Years 2001-2004. PACE 2006; 29 (Suppl 2): S20-S28.
10. DUBNER S, VALERO E, PESCE R, ZUELGARAY JG, MATEOS JC, FILHO SG, REYES W ET AL: A Latin American registry of implantable cardioverter defibrillators: the ICD-LABOR study. Ann Noninvasive Electrocardiol. 2005; 10(4): 420-8.
11. GREENBERG SM, EPSTEIN AE, DEERING T, GOLDMAN DS, GHIDINA M, NEASON C, PROCLAMER A: A Comparison of ICD Implantations in the United States Versus Italy. Pacing Clin Electrophysiol 2007; 30 (Suppl 1): S143-6.
12. Danish Pacemaker and ICD Register. www.pacemaker.dk. 2004.
13. PEINADO R, ARENAL A, ARRIBAS F, TORRECILLA E, ALVAREZ M ORMAETXE JM, PEREZ-CASTELLANO N: Spanish implantable cardioverter-defibrillator registry. First official report of the spanish society of cardiology working group on implantable cardioverter- defibrillators(2002-2004). Rev Esp Cardiol 2005; 58(12): 1435-49.
14. HAVRANEK E, MASOUDI F, WESTFALL K, WOLFE P, ORDIN DL, KRUMHOLZ HM: Spectrum of heart failure in older patients: results from the National Heart Failure project. Am Heart J 2002; 143(3): 412-7.
15. The DAVID trial investigators. Dual-chamber pacing or ventricular backup pacing in patients with an implantable defibrillator. JAMA 2002; 288(24): 3115-3123.
16. MOSS AJ: MADIT-II: substudies and their implications. Card Electrophysiol Rev 2003; 7(4): 430-3.
17. EVADEF investigators. EVADEF Registry, main data. Arch Mal Coeur Vaiss 2007; 100(2): 99-103.